[1]
|
Zuberbier, T., AbdulLatiff, A.H., Abuzakouk, M., et al. (2022) The International EAACI/GA2LEN/EuroGuiDerm/APAAACI Guideline for the Definition, Classification, Diagnosis, and Management of Urticaria. Allergy, 77, 734-766. https://doi.org/10.1111/all.15090
|
[2]
|
Park, H.J., Montgomery, J.R. and Boggs, N.A. (2021) Anaphylaxis after the COVID-19 Vaccine in a Patient with Cholinergic Urticaria. Military Medicine, 187, e1556-e15578. https://doi.org/10.1093/milmed/usab138
|
[3]
|
Zhong, H., Song, Z., Chen, W., et al. (2014) Chronic Urticaria in Chinese Population: A Hospital-Based Multicenter Epidemiological Study. Allergy, 69, 359-364. https://doi.org/10.1111/all.12338
|
[4]
|
Kim, J.E., Eun, Y.S., Park, Y.M., et al. (2014) Clinical Characteristics of Cholinergic Urticaria in Korea. Annals of Dermatology, 26, 189-194. https://doi.org/10.5021/ad.2014.26.2.189
|
[5]
|
Mellerowicz, E.J., Asady, A., Maurer, M., et al. (2019) Angioedema Frequently Occurs in Cholinergic Urticaria. The Journal of Allergy and Clinical Immunology: In Practice, 7, 1355-1357. https://doi.org/10.1016/j.jaip.2018.10.013
|
[6]
|
Chol Urch, M.K. (2017) Allergy, Histamine and Antihistamines. In: Hattori, Y. and Seifert, R., Eds., Histamine and Histamine Receptors in Health and Disease, Springer, Cham, 321-331. https://doi.org/10.1007/164_2016_85
|
[7]
|
Nakamizo, S., Egawa, G., Miyachi, Y. and Kabashima, K. (2012) Cholinergic Urticaria: Pathogenesis-Based Categorizationand Its Treatment Options. Journal of the European Academy of Dermatology and Venereology, 26, 114-116. https://doi.org/10.1111/j.1468-3083.2011.04017.x
|
[8]
|
Altrichter, S., Koch, K., Chol Urch, M.K., et al. (2016) Atopic Predisposition in Cholinergic Urticaria Patients and Its Implications. Journal of the European Academy of Dermatology and Venereology, 30, 2060-2065. https://doi.org/10.1111/jdv.13765
|
[9]
|
Adachi, J., Aoki, T. and Yamatodani, A. (1994) Demonstration of Sweat Allergy in Cholinergic Urticaria. Journal of Dermatological Science, 7, 142-149. https://doi.org/10.1016/0923-1811(94)90088-4
|
[10]
|
Hiragun, T., Ishii, K., Hiragun, M., Suzuki, H., Kan, T., Mihara, S., Yanase, Y., Bartels, J., Schröder, J.M. and Hide, M. (2013) Fungal Protein MGL_1304 in Sweat Is an Allergen for Atopic Dermatitis Patients. The Journal of Allergy and Clinical Immunology, 132, 608-615. E4. https://doi.org/10.1016/j.jaci.2013.03.047
|
[11]
|
Hiragun, M., Hiragun, T., lshii, K., Suzuki, H., Tanaka, A., Yanase, Y., Ihara, S., Haruta, Y., Kohno, N. and Hide, M. (2014) Elevated Serum IgE against MGL_1304 in Patients with Atopic Dermatitis and Cholinergic Urticaria. Allergology International, 63, 83-93. https://doi.org/10.2332/allergolint.13-OA-0611
|
[12]
|
Kobayashi, H., Aiba, S., Yamagishi, T., Tanita, M., Hara, M., Saito, H. and Tagami, H. (2002) Cholinergic Urticaria, a New Pathogenic Concept: Hypohidrosis due to Interference with the Delivery of Sweat to the Skin Surface. Dermatology. 204, 173-178. https://doi.org/10.1159/000057877
|
[13]
|
Sawada, Y., Nakamura, M., Bito, T., Fukamachi, S., Kabashima, R., Sugita, K., Hino, R. and Tokura, Y. (2010) Cholinergic Urticaria: Studies on the Muscarinic Cholinergic Receptor M3 in Anhidrotic and Hypohidrotic Skin. Journal of Investigative Dermatology, 130, 2683-2686. https://doi.org/10.1038/jid.2010.188
|
[14]
|
Sawada, Y., Nakamura, M., Bito, T., Sakabe, J.I., Kabashima-Kubo, R., Hino, R., Kobayashi, M. and Tokura, Y. (2014) Decreased Expression of Acetylcholine Esterase in Cholinergic Urticaria with Hypohidrosis or Anhidrosis. Journal of Investigative Dermatology, 134, 276-279. https://doi.org/10.1038/jid.2013.244
|
[15]
|
Takahagi, S., Tanaka, T., Ishii, K., Suzuki, H., Kameyoshi, Y., Shindo, H. and Hide, M. (2009) Sweat Antigen Induces Histamine Release from Basophils of Patients with Cholinergic Urticaria Associated with Atopic Diathesis. British Journal of Dermatology, 160, 426-428. https://doi.org/10.1111/j.1365-2133.2008.08862.x
|
[16]
|
Fukunaga, A., Washio, K., Hatakeyama, M., et al. (2018) Cholinergic Urticaria: Epidemiology, Physiopathology, New Categorization, and Management. Clinical Autonomic Research, 28, 103-113. https://doi.org/10.1007/s10286-017-0418-6
|
[17]
|
朱世增. 朱仁康论皮肤科[M]. 上海: 上海中医药大学出版社, 2008: 10-19.
|
[18]
|
Koch, K., Weller, K., Werner, A., Maurer, M. and Altrichter, S. (2016) Antihistamine Updosing Reduces Disease Activity in Patients with Difficult-to-Treat Cholinergic Urticaria. The Journal of Allergy and Clinical Immunology, 138, 1483-1485. E9. https://doi.org/10.1016/j.jaci.2016.05.026
|
[19]
|
Murphy, G.M., Black, A.K. and Greaves, M.W. (1983) Persisting Cholinergic Erythema: A Variant of Cholinergic Urticaria. British Journal of Dermatology, 109, 343-348. https://doi.org/10.1111/j.1365-2133.1983.tb03551.x
|
[20]
|
Mayou, S.C., Kobza Black, A., Eady, R.A. and Greaves, M.W. (1986) Cholinergic Dermographism. British Journal of Dermatology, 115, 371-377. https://doi.org/10.1111/j.1365-2133.1986.tb05754.x
|
[21]
|
Tsunemi, Y., Ihn, H., Saeki, H. and Tamaki, K. (2003) Cholinergic Urticaria Successfully Treated with Scopolamine Butylbromide. International Journal of Dermatology, 42, 850. https://doi.org/10.1046/j.1365-4362.2003.02010.x
|
[22]
|
Gastaminza, G., Azofra, J., Nunez-Cordoba, J.M., Baeza, M.L., Echechipía, S., Gaig, P., García, B.E., Labrador-Horrillo, M., Sala-Cunill, A., Brescó, M.S., Beristain, A., Quiñones, D., Donado, C.D., Zubeldia, J.M. and Ferrer, M. (2019) Efficacy and Safety of Omalizumab (Xolair) for Cholinergic Urticaria in Patients Unresponsive to a Double Dose of Antihistamines: A Randomized Mixed Double-Blind and Open-Label Placebo-Controlled Clinical Trial. The Journal of Allergy and Clinical Immunology: In Practice, 7, 1599-1609. E1. https://doi.org/10.1016/j.jaip.2018.12.025
|
[23]
|
Bodar, E.J., Simon, A., de Visser, M., et al. (2009) Complete Remission of Severe Idiopathic Cold Urticaria on Interleukin-1 Receptor Antagonist (Anakinra). The Netherlands Journal of Medicine, 67, 302-305.
|
[24]
|
Fukunaga, A., Hatakeyama, M., Tsujimoto, M., Oda, Y., Washio, K. and Nishigori, C. (2015) Steroid Treatment Can Improve the Impaired Quality of Life of Patients with Acquired Idiopathic Generalized Anhidrosis. British Journal of Dermatology, 172, 537-538. https://doi.org/10.1111/bjd.13285
|
[25]
|
Fukunaga, A., Oda, Y., Imamura, S., et al. (2022) Cholinergic Urticaria: Subtype Classification and Clinical Approach. American Journal of Clinical Dermatology, 24, 41-54. https://doi.org/10.1007/s40257-022-00728-6
|
[26]
|
张堂德, 徐明书 ,周冼苡, 等. 丹那唑治疗胆碱能性荨麻疹的临床实验观察[J]. 中国皮肤性病学杂志, 1996(2): 114-115.
|
[27]
|
张炜摘, 陈又. 胆碱能性荨麻疹[J]. 国外医学皮肤性病学分册, 1982, 8(3): 171-172.
|
[28]
|
Kozaru, T., Fukunaga, A., Taguchi, K., Ogura, K., Nagano, T., Oka, M., Horikawa, T. and Nishigori, C. (2011) Rapid Desensitization with Autologous Sweat in Cholinergic Urticaria. Allergology International, 60, 277-281. https://doi.org/10.2332/allergolint.10-OA-0269
|
[29]
|
李凤仙, 燕陶然, 毕雪梅. 从营血论治胆碱能性荨麻疹[J]. 中医药研究, 1998(3): 50-51.
|
[30]
|
蔡秀珍, 郭丽珠, 高建平, 林宝珍. 防风通圣散治疗胆碱能性荨麻疹60例疗效观察[J]. 河北中医, 2001, 23(11): 835-836.
|
[31]
|
高飞凌, 于学仁. 桂枝麻黄各半汤加味治疗胆碱能性荨麻疹45例[J]. 中国民间疗法, 2006, 14(11): 39-40. https://doi.org/10.19621/j.cnki.11-3555/r.2006.11.039
|
[32]
|
方玉甫, 刘爱民. 丹栀逍遥散治疗胆碱能性荨麻疹临床观察[J]. 四川中医, 2009, 27(9): 90-91.
|
[33]
|
陶甜甜, 张云璧, 李建红, 等. 过敏煎实验与临床应用研究综述[J]. 中华中医药杂志, 2018, 33(1): 242-244.
|
[34]
|
张恩虎, 李红涛, 张璐璐. 加味过敏煎治疗慢性荨麻疹30例临床观察[J]. 江苏中医药, 2007, 39(10):50-51.
|
[35]
|
黄时燕, 赵晓广, 聂巧峰. 过敏煎加减辨证治疗慢性荨麻疹临床疗效观察[J]. 实用中西医结合临床, 2012, 12(3): 67-68.
|
[36]
|
刘真真, 钟海森, 陶鑫, 等. 加味过敏煎对荨麻疹抗过敏药效作用的研究[J]. 西部中医药, 2022, 35(6): 21-24.
|
[37]
|
梁玉丹, 陈秀华, 马碧茹. 《中华医典》针灸治疗荨麻疹的古代文献计量分析[J]. 国际中医中药杂志, 2019, 41(5): 506-509. https://doi.org/10.3760/cma.j.issn.1673-4246.2019.05.016
|
[38]
|
刘景卫, 郝玉, 甄翠棉, 等. 中医耳针联合咪唑斯汀治疗胆碱能性荨麻疹临床观察[J]. 中国皮肤性病学杂志, 2007, 21(8): 516-517.
|
[39]
|
李金娥, 康明非, 吕曹华, 等. “热敏点”灸治疗血虚风燥型慢性荨麻疹30例[J]. 福建中医药, 2009, 40(1): 13-14.
|
[40]
|
王丽娜, 杨玉峰, 蒲继红, 等. 桑叶消风颗粒配合穴位埋线治疗胆碱能性荨麻疹的疗效观察[J]. 现代中医药, 2014, 34(4): 29-30. https://doi.org/10.13424/j.cnki.mtcm.2014.04.013
|
[41]
|
胡秀荣, 田晓晔. 采用血海穴注射丹皮酚治疗胆碱能性荨麻疹9例[J]. 辽宁中医学院学报, 2006, 8(3): 87.
|